Ellagic acid, a dietary polyphenol, selectively cytotoxic to HSC-2 oral carcinoma cells

Anticancer Research

Volumn 33, Issue 5, 2013, Pages 1829-1836

  Weisburg, Jeffrey H ^a   Schuck, Alyssa G ^a   Reiss, Sarah E ^a   Wolf, Bella J ^a   Fertel, Simone R ^a   Zuckerbraun, Harriet L ^a   Babich, Harvey ^a  

^a YESHIVA UNIVERSITY   (United States)

Author keywords

Antioxidant; Antiproliferative; Apoptosis; Ellagic acid; H5C 2 oral carcinoma cells; Pro oxidant

Indexed keywords

CASPASE 3; CASPASE 7; DICHLORODIHYDROFLUORESCEIN DIACETATE; ELLAGIC ACID; FERROUS ION; GALLIC ACID; GLUTATHIONE; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLYPHENOL;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUMINESCENCE; MOUTH SQUAMOUS CELL CARCINOMA; OXIDATION; PRIORITY JOURNAL;

ANTIOXIDANT; ANTIPROLIFERATIVE; APOPTOSIS; ELLAGIC ACID; H5C-2 ORAL CARCINOMA CELLS; PRO-OXIDANT;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; ELLAGIC ACID; HUMANS; MOUTH NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84878212574     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sakagami H: Apoptosis-inducing activity and tumor-specificity of antitumor agents against oral squamous carcinoma. Jpn Dent Sci Rev 46: 173-187, 2010.
2. Fukumoto LR and Mazza G: Assessing antioxidant and prooxidant activities of phenolic compounds. J Agric Food Chem 48: 3597-3604, 2002.
3. Weisburg JH, Weisman DB, Sedaghat T and Babich H: In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity. Basic Clin Pharmacol Toxicol 95: 191-200, 2004. (Pubitemid 39472964)
4. Schuck AG, Ausubel MB, Zuckerbraun HL and Babich H: Theaflavin-3, 3′-digallate, a component of black tea: An inducer of oxidative stress and apoptosis. Toxicol In Vitro 22: 598-609, 2008.
5. Babich H, Krupka ME, Nissim HA and Zuckerbraun HL: Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity. Toxicol In Vitro 19: 231-242, 2005. (Pubitemid 40092747)
6. Festa F, Aglitti T, Duranti G, Ricordy R, Perticone P and Cozzi R: Strong antioxidant activity of ellagic acid in mammalian cells in vitro revealed by the comet assay. Anticancer Res 21: 3903-3908, 2001. (Pubitemid 34229261)
7. Edderkaoui M, Odinokova I, Ono I, Gukovsky I, Go VLW, Pandol SJ and Gukovskaya AS: Ellagic acid induces apoptosis through inhibition of nuclear factor κB in pancreatic cancer cells. World J Gastoenterol 14: 3672-3680, 2008.
8. Losso JN, Bansode RR, Trappey A, Bawadi HA and Truax R: In vitro antiproliferative activities of ellagic acid. J Nutr Biochem 15: 672-678, 2004. (Pubitemid 39611365)
9. Hagiwara Y, Kasukabe T, Kaneko Y, Niitsu N and Okabe-Kado J: Ellagic acid, a natural polyphenolic compound induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells. Int J Hematol 92: 136-143, 2010.
10. Fjaeraa C and Nanberg E: Effect of ellagic acid on proliferation, cell adhesion and apoptosis in SH-SY5Y human neuroblastoma cells. Biomed Pharmacother 63: 254-261, 2009.
11. Gonzalez-Sarrias A, Espin J-C, Tomas-Barberan FA and Garcia- Conesa M-T: Gene expression, cell cycle arrest and MAPK signaling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Mol Nutr Food Res 53: 686-698, 2009.
12. Han DH, Lee, MJ and Kim JH: Antioxidant and apoptosis-inducing activities of ellagic acid. Anticancer Res 26: 3601-3606, 2006. (Pubitemid 44701545)
13. Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair, MG and Heber D: In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16: 360-367, 2005. (Pubitemid 40776045)
14. Babich H, Liebling EJ, Burger RF, Zuckerbraun HL and Schuck AG: Choice of DMEM, formulated with or without pyruvate, plays an important role in assessing the in vitro cytotoxicity of oxidants and pro-oxidant nutraceuticals. In Vitro Cell Dev Biol 45: 226-233, 2009.
15. Weisburg JH, Schuck AG, Silverman MS, Ovits-Levy CG, Solodokin LJ, Zuckerbraun HL and Babich H: Pomegranate extract, a pro-oxidant with antiproliferative and proapoptotic activities preferentially towards carcinoma cells. Anticancer Agts Med Chem 10: 634-644, 2010.
16. Wee LM, Long LH, Whiteman M and Halliwell B: Factors affecting the ascorbate- and phenolic-dependent generation of hydrogen peroxide in Dulbecco's modified Eagle's medium, Free Radic Res 37: 1123-1130, 2003. (Pubitemid 37265335)
17. You R, Kim SZ, Kim SH and Park WH: Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion. Mol Cell Biochem 357: 295-303, 2011.
18. Pavlica S and Gebhardt R: Protective effects of ellagic and chlorogenic acids against oxidative stress in PC12 cells. Free Rad Res 39: 1377-1390, 2005. (Pubitemid 43023803)